Analysts await Inogen, Inc (NASDAQ:INGN) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $0.12 EPS, up 33.33% or $0.04 from last year’s $0.08 per share.

At the moment 6 analysts are watching Inogen, Inc (NASDAQ:INGN), 4 rate it “Buy”, 1 “Outperform”, 1 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 6 analysts have a mean sales target of 52.99 million. For the quarter ending Sep-16, 6 analysts have a mean sales target of 48.14 million whilst for the year ending Dec-16, 6 analysts have a mean target of 189.19 million.

In terms of earnings per share, 6 analysts have a 0.19 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 6 analysts have a 0.16 EPS mean target and for the quarter ending Sep-16 there are 6 estimates of 0.60 EPS.

The biggest institutional shareholders in Inogen, Inc include Novo A/S which owns 4 million shares in the company valued at $142.29 million. BlackRock Fund Advisors is the second biggest holder with 1 million shares currently valued at 40.79 million whilst Wells Fargo Bank NA has 1 million shares valued at 40.65 million.

Total shares held by institutions as of the most recent company filings are 20,762,586 with a reported 2,444,644 bought and 901,850 sold. These holdings make up 97.4% of the company’s outstanding shares.

Currently insiders hold 203,432 shares in the business which makes up 1.03% of shares. The biggest holder currently is Mr. Byron Myers who owns 48,185 shares (0.24% of those outstanding), whilst Mr. Scott Wilkinson holds 39,344 (0.20% of shares outstanding) and Ms. Alison Bauerlein holds 38,332 (0.19% of shares outstanding).

The stock decreased 0.56% or $0.27 during the last trading session.